Activating a person’s immune response against cancer is one of the most exciting advances in cancer therapy
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Normally our immune system fails to recognise cancer cells, as they can look like normal cells in our body and are adept at becoming invisible to immune cells. By making the cancer cells visible to the immune system, new immunotherapies can potentially be used to cure cancer.
Cancer immunotherapy – involving treatments that harness the body’s own immune system to destroy tumours – is currently one of the most exciting areas of dramatic progress in cancer research. And CRIS, has already played an important role in developing immunotherapy for patients.
CRIS Cancer Foundation wants to invest further in this important field of science, and so has donated £1.3 million to The Institute of Cancer Research (ICR), to ensure their advances in cancer research benefit patients now and in the long-term. Together, CRIS and ICR, have recruited a new team which is solely dedicated to immunotherapy, funded 100% by CRIS, researching in synergy within the new state-of-the-art Centre for Cancer Drug Discovery. Furthermore, this new team will share their findings and results worldwide to find answers to the most clinically-challenging problems in cancer research, such as how to combat drug resistance.
CRIS has already generously supported the ICR’s research over the last few years, with a focus on haemato-oncology and childhood cancer. Now, CRIS has chosen to continue its support go the ICR in this highly area of research: IMMUNOTHERAPY.